These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10525062)

  • 1. Effects of regulators of G protein-signaling proteins on the functional response of the mu-opioid receptor in a melanophore-based assay.
    Potenza MN; Gold SJ; Roby-Shemkowitz A; Lerner MR; Nestler EJ
    J Pharmacol Exp Ther; 1999 Nov; 291(2):482-91. PubMed ID: 10525062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
    Clark MJ; Traynor JR
    J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous regulator of G protein signaling proteins suppress Galphao-dependent, mu-opioid agonist-mediated adenylyl cyclase supersensitization.
    Clark MJ; Neubig RR; Traynor JR
    J Pharmacol Exp Ther; 2004 Jul; 310(1):215-22. PubMed ID: 15014136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Garzón J
    Mol Pain; 2007 Jul; 3():19. PubMed ID: 17634133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell imaging of intracellular Ca2+ and phospholipase C activity reveals that RGS 2, 3, and 4 differentially regulate signaling via the Galphaq/11-linked muscarinic M3 receptor.
    Tovey SC; Willars GB
    Mol Pharmacol; 2004 Dec; 66(6):1453-64. PubMed ID: 15383626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine alters the selective association between mu-opioid receptors and specific RGS proteins in mouse periaqueductal gray matter.
    Garzón J; Rodríguez-Muñoz M; Sánchez-Blázquez P
    Neuropharmacology; 2005 May; 48(6):853-68. PubMed ID: 15829256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
    Xu H; Wang X; Wang J; Rothman RB
    Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RGS-insensitive G-protein mutations to study the role of endogenous RGS proteins.
    Fu Y; Zhong H; Nanamori M; Mortensen RM; Huang X; Lan K; Neubig RR
    Methods Enzymol; 2004; 389():229-43. PubMed ID: 15313569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assays for G-protein-coupled receptor signaling using RGS-insensitive Galpha subunits.
    Clark MJ; Traynor JR
    Methods Enzymol; 2004; 389():155-69. PubMed ID: 15313565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling.
    Georgoussi Z; Leontiadis L; Mazarakou G; Merkouris M; Hyde K; Hamm H
    Cell Signal; 2006 Jun; 18(6):771-82. PubMed ID: 16120478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflects functional interactions.
    Roy AA; Lemberg KE; Chidiac P
    Mol Pharmacol; 2003 Sep; 64(3):587-93. PubMed ID: 12920194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of melatonin and its downstream effector PKCalpha on subcellular localization of RGS proteins.
    Rimler A; Jockers R; Lupowitz Z; Sampson SR; Zisapel N
    J Pineal Res; 2006 Mar; 40(2):144-52. PubMed ID: 16441551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous RGS proteins and Galpha subtypes differentially control muscarinic and adenosine-mediated chronotropic effects.
    Fu Y; Huang X; Zhong H; Mortensen RM; D'Alecy LG; Neubig RR
    Circ Res; 2006 Mar; 98(5):659-66. PubMed ID: 16456099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine desensitization, internalization, and down-regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation.
    Lopez-Gimenez JF; Vilaró MT; Milligan G
    Mol Pharmacol; 2008 Nov; 74(5):1278-91. PubMed ID: 18703670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S1P receptor signalling and RGS proteins; expression and function in vascular smooth muscle cells and transfected CHO cells.
    Hendriks-Balk MC; van Loenen PB; Hajji N; Michel MC; Peters SL; Alewijnse AE
    Eur J Pharmacol; 2008 Dec; 600(1-3):1-9. PubMed ID: 18854184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of RGS-insensitive Galpha subunits to study endogenous RGS protein action on G-protein modulation of N-type calcium channels in sympathetic neurons.
    Ikeda SR; Jeong SW
    Methods Enzymol; 2004; 389():170-89. PubMed ID: 15313566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling.
    Leontiadis LJ; Papakonstantinou MP; Georgoussi Z
    Cell Signal; 2009 Jul; 21(7):1218-28. PubMed ID: 19324084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knock-down of RGS4 and beta tubulin in CHO cells expressing the human MT1 melatonin receptor prevents melatonin-induced receptor desensitization.
    Witt-Enderby PA; Jarzynka MJ; Krawitt BJ; Melan MA
    Life Sci; 2004 Oct; 75(22):2703-15. PubMed ID: 15369705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of receptor-selective effects of either RGS2, RGS3 or RGS4 on muscarinic M3- and gonadotropin-releasing hormone receptor-mediated signalling through G alpha q/11.
    Karakoula A; Tovey SC; Brighton PJ; Willars GB
    Eur J Pharmacol; 2008 Jun; 587(1-3):16-24. PubMed ID: 18457830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of regulator of G protein signaling (RGS) proteins on serotonin 5-HT1A, 5-HT2A, and dopamine D2 receptor-mediated signaling and adenylyl cyclase activity.
    Ghavami A; Hunt RA; Olsen MA; Zhang J; Smith DL; Kalgaonkar S; Rahman Z; Young KH
    Cell Signal; 2004 Jun; 16(6):711-21. PubMed ID: 15093612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.